These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 10643978

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
    Wolf JC, Ginn PE, Homer B, Fox LE, Kurzman ID.
    Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
    [Abstract] [Full Text] [Related]

  • 4. Cytologic Criteria for Mast Cell Tumor Grading in Dogs With Evaluation of Clinical Outcome.
    Camus MS, Priest HL, Koehler JW, Driskell EA, Rakich PM, Ilha MR, Krimer PM.
    Vet Pathol; 2016 Nov; 53(6):1117-1123. PubMed ID: 27034386
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M, Webster JD, Kaneene JB, Miller R, Yuzbasiyan-Gurkan V.
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [Abstract] [Full Text] [Related]

  • 7. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
    Gieger TL, Théon AP, Werner JA, McEntee MC, Rassnick KM, DeCock HE.
    J Vet Intern Med; 2003 Jul; 17(5):687-92. PubMed ID: 14529136
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs.
    Abadie JJ, Amardeilh MA, Delverdier ME.
    J Am Vet Med Assoc; 1999 Dec 01; 215(11):1629-34. PubMed ID: 14567425
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M, Giantin M, Capello K, Carminato A, Morello EM, Vercelli A, Granato A, Buracco P, Dacasto M, Mutinelli F.
    Vet Pathol; 2013 Jan 01; 50(1):110-21. PubMed ID: 22673539
    [Abstract] [Full Text] [Related]

  • 13. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog.
    Preziosi R, Morini M, Sarli G.
    J Vet Diagn Invest; 2004 Nov 01; 16(6):554-61. PubMed ID: 15586571
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.
    Michels GM, Knapp DW, DeNicola DB, Glickman N, Bonney P.
    J Am Anim Hosp Assoc; 2002 Nov 01; 38(5):458-66. PubMed ID: 12220031
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
    Hahn KA, King GK, Carreras JK.
    J Am Vet Med Assoc; 2004 Jan 01; 224(1):79-82. PubMed ID: 14710881
    [Abstract] [Full Text] [Related]

  • 17. Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors.
    Book AP, Fidel J, Wills T, Bryan J, Sellon R, Mattoon J.
    Vet Radiol Ultrasound; 2011 Jan 01; 52(5):548-54. PubMed ID: 21689203
    [Abstract] [Full Text] [Related]

  • 18. Association of histologic tumor characteristics and size of surgical margins with clinical outcome after surgical removal of cutaneous mast cell tumors in dogs.
    Schultheiss PC, Gardiner DW, Rao S, Olea-Popelka F, Tuohy JL.
    J Am Vet Med Assoc; 2011 Jun 01; 238(11):1464-9. PubMed ID: 21627510
    [Abstract] [Full Text] [Related]

  • 19. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
    Sfiligoi G, Rassnick KM, Scarlett JM, Northrup NC, Gieger TL.
    J Am Vet Med Assoc; 2005 Apr 15; 226(8):1368-74. PubMed ID: 15844431
    [Abstract] [Full Text] [Related]

  • 20. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs.
    Kravis LD, Vail DM, Kisseberth WC, Ogilvie GK, Volk LM.
    J Am Vet Med Assoc; 1996 Oct 15; 209(8):1418-20. PubMed ID: 8870737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.